# TG Therapeutics, Inc.: Form 8-K, filed Feb 28, 2023

- Company: [TG Therapeutics, Inc.](/companies/tgtx.md) (CIK 1001316)
- Form: 8-K
- Filed: 2023-02-28
- Accepted by EDGAR: Feb 28, 2023, 07:33 ET
- Period: 2023-02-28
- Accession: 0001558370-23-002239
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001316/000155837023002239/tgtx-20230228x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001316/000155837023002239/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001316/000155837023002239/tgtx-20230228x8k.htm

Filed Feb 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-002239. Last ingested by Listed: Nov 10, 2026, 03:15 ET. No prices; not investment advice.
